STAT
NOVEMBER 13, 2024
A Canadian teenager who is in critical condition after contracting H5N1 bird flu was infected with a version of the virus that is different from the one circulating in dairy cattle in the United States, Canadian authorities announced Wednesday. The National Microbiology Laboratory in Winnipeg confirmed the infection was indeed caused by the H5N1 virus.
PharmaVoice
NOVEMBER 13, 2024
As the industry’s marketing dollars shift, companies are targeting potential patients in unique ways.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 13, 2024
U.S. drug overdose deaths are plummeting, putting the country on pace for its first year with fewer than 100,000 overdose deaths since 2020 — a powerful, if bleak, symbolic milestone. Reported drug deaths fell nearly 17% during the 12-month period ending in June, to 93,087, according to new statistics released this week by the Centers for Disease Control and Prevention.
BioPharma Dive
NOVEMBER 13, 2024
Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit Therapeutics’ ivonescimab over Keytruda.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 13, 2024
Several years ago, teams of scholars published groundbreaking research that pointed to racial biases in algorithms that helped direct patient care at major health systems in the U.S. Those algorithms, the studies found, adversely affected the care of Black and Latinx patients across multiple medical categories. For instance, the researchers uncovered racial biases in the prediction algorithms used by to identify more medically complex patients, such that Black patients were far less likely to qu
The Pharmacist
NOVEMBER 13, 2024
Pharmacy owners in England, Wales and Northern Ireland have voted in favour of taking collective action, according to a ballot carried out by the National Pharmacy Association (NPA). Some 99% of participating pharmacy owners said they were willing to limit their services unless funding is improved. The NPA said that subject to agreement from its […] The post Pharmacy owners vote overwhelmingly in favour of collective action appeared first on The Pharmacist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
NOVEMBER 13, 2024
Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS use of Sarclisa as a treatment for relapsed and refractory multiple myeloma (RRMM).The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside Bristol-Myers Squibb/Celgene's Imnovid (pomalidomide) and dexamethasone (Isa-Pd) for relapsed RRMM.
STAT
NOVEMBER 13, 2024
Until Jennifer Cortes joined a patient advocacy group of adults who have congenital heart defects, she’d never met anyone outside her family who was living with such a complex, life-changing condition. Because she hears that sentiment so often in her volunteer work with the group, she has a ready answer. “I tell them they’re not alone.
Express Pharma
NOVEMBER 13, 2024
The 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26-28, 2024, at the India Expo Centre, Greater Noida, Delhi-NCR. Renowned as a comprehensive, one-stop destination for innovative, cost-effective solutions, the expo will be showcasing the pharmaceutical industry’s modernisation, innovation, and sustainability.
STAT
NOVEMBER 13, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, lots of news this morning that we’ll get straight into.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
NOVEMBER 13, 2024
UCB and Biogen’s Phase III PHOENYCS GO trial results signal a pivotal development for systemic lupus erythematosus (SLE) treatment, as dapirolizumab pegol met its primary endpoint and demonstrated enhanced disease control and safety at Week 48. With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established SLE treatments and address unmet needs in an increasingly competitive therapeutic landscape, according to GlobalData.
STAT
NOVEMBER 13, 2024
The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken sandwiches and burritos to Silk Road Medical employees in California and Minnesota, before holding a town hall-style meeting to welcome them into the fold. That September day was a big one for the teams at Silk Road , which makes stroke-prevention devices.
pharmaphorum
NOVEMBER 13, 2024
More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US.The FDA has approved PTC's eladocagene exuparvovec – known as Upstaza in Europe – under the Kebilidi trade name in the US. It is cleared for both children and adults with AADC (aromatic L-amino acid decarboxylase) deficiency, a fatal disease that causes severe disability and suffering from the first months of life.
The Pharmacist
NOVEMBER 13, 2024
We caught up with the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards ceremony to be held on 6 December at the Novotel London West. The Orpington PCN Pharmacy Team has grown from a group of five to a thriving team of 13 over the past 18 months, comprising […] The post GP Awards shortlist: Orpington PCN Pharmacy Team appeared first on The Pharmacist.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Safe Biologics
NOVEMBER 13, 2024
Click here to download the Myth vs Fact Onepager.
Pharmaceutical Technology
NOVEMBER 13, 2024
Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics and sterile injectables used in hospitals and clinics, Reuters reported.
Pharmafile
NOVEMBER 13, 2024
Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the European Medicines agency (EMA) for the approval of a new indication for DARAZALEX FASPRO (daratumumab and hyluronidase-fihj). DARAZLEX FASPRO would be used as a monotherapy for the treatment of high-risk smoldering multiple myeloma in adult […] The post J&J seek approval for first drug to treat high-risk smoldering myeloma appeared first on Pharmafile.
Med Ed 101
NOVEMBER 13, 2024
Two tests are commonly used in asthma assessments to monitor symptom control and airflow and this blog post will discuss their use and how they determine appropriate treatment options. Important tests pharmacists should know include the Asthma Control Test and a Peak Expiratory Flow. We will discuss them below. Asthma Control Test The first of two […] The post Two Asthma Assessments That Pharmacists Should Know appeared first on Med Ed 101.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
NOVEMBER 13, 2024
A spray sold to delay ejaculation has been recalled after its manufacturer revealed it was not authorised by the Medicines and Healthcare Products Regulatory Agency (MHRA). The EXS Delay Spray Plus contains lidocaine, a local anaesthetic. But the product has not undergone the appropriate assessments related to safety, quality and efficacy, the MHRA said today. […] The post Unauthorised ejaculation delay spray recalled by MHRA appeared first on The Pharmacist.
European Pharmaceutical Review
NOVEMBER 13, 2024
New clinical trial findings show that twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP) had high efficacy and safety in a diverse group of participants. This data provides the first in-depth insight into full results of Gilead Sciences pivotal Phase III PURPOSE 2 trial. In the oral PrEP study group, adherence to the small molecule injectable HIV-1 capsid inhibitor and placebo injections was 91.0 percent with on-time injections at week 26, the results showed.
Express Pharma
NOVEMBER 13, 2024
AptarGroup announced the inauguration of its new pharma plant in Taloja, India, near Mumbai. The facility will help Aptar continue to meet the growing demands of the pharmaceutical industry in India. The new facility will expand the company’s existing footprint in the region while adding additional local production of several technologies including Aptar’s pressurised metered-dose inhaler (pMDI) valve, as well as breath-actuated devices and single-dose nasal sprays.
Outsourcing Pharma
NOVEMBER 13, 2024
Driven by the effects of the COVID-19 pandemic, the market for decentralized clinical trials has seen a push that will lead it to more than triple in size within the next decade.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Channels
NOVEMBER 13, 2024
Uh oh. As I predicted, the stand-alone Medicare Part D prescription drug plans (PDP) market is vanishing. For 2025, DCI’s exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that the number of PDPs will drop to a historic low. What’s more, the share of plans with a preferred cost sharing pharmacy network will fall to its lowest rate in more than 10 years.
The Pharmacist
NOVEMBER 13, 2024
A pharmacogenetics pilot supported by pharmacists working within general practice has resulted in medicines changes for 25% of participating patients so far, Royal Pharmaceutical Society (RPS) conference attendees heard last week. Jessica Keen, pharmacy lead at the NHS North West Genomic Medicines Service Alliance, shared an update on the NHS England-funded Pharmacogenetics Roll Out – Gauging Response to Service (PROGRESS) […] The post Pharmacogenetics pilot in general practice suggests 25
pharmaphorum
NOVEMBER 13, 2024
London is the top city in Europe for the life sciences industry, and ranks third worldwide after Boston and New York in the US, says MedCity report
Express Pharma
NOVEMBER 13, 2024
Bristol Myers Squibb and Cabaletta Bio are set to present promising Phase I data on CD19-directed CAR T therapies for severe, refractory lupus at the American College of Rheumatology 2024. BMS’s CC-97540 and Cabaletta Bio’s CABA-201 showed significant efficacy, offering new hope for severe, refractory lupus and other challenging autoimmune diseases.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
NOVEMBER 13, 2024
New long-term partnership to address neurological disorder treatments
Outsourcing Pharma
NOVEMBER 13, 2024
A recent Lindus Health survey emphasizes the importance of patient-centered designs in clinical trials, particularly highlighting how telehealth options could improve accessibility and convenience for participants.
Pharma Times
NOVEMBER 13, 2024
First patient dosed in phase 1b trial of MB310 therapy
pharmaphorum
NOVEMBER 13, 2024
Amgen has rebuffed claims made by an analyst suggesting that its obesity drug MariTide is associated with reductions in bone mineral density
Outsourcing Pharma
NOVEMBER 13, 2024
Traditional clinical trials usually rely on several physical trial sites to recruit and monitor patients.
Expert insights. Personalized for you.
363 
Let's personalize your content